Developer docs
API playgroundTry for free, no card

Search company profiles

Teva Uk Limited

Full company profile

uuid00ymzpo

Namestring
Teva Uk Limited
Legal namestring
Teva UK Limited
Websiteurl
tevauk.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Teva UK Limited is a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and one of the largest pharmaceutical companies operating in the United Kingdom. The company develops, manufactures, and supplies a portfolio spanning generic medicines, innovative branded products, biosimilars, and over-the-counter consumer healthcare brands (Sudocrem, Infacol, Motusol), with 650+ generic product lines distributed to millions of UK patients daily. UK operations are anchored by four sites: Castleford (headquarters and high-tech logistics centre), Runcorn (sterile liquid manufacturing for respiratory and neurological treatments, serving global markets), Harlow (Centre of Excellence for Regulatory Affairs covering European and global licensing), and Larne (hormonal ring manufacturing and intrauterine device R&D). Wholly-owned subsidiaries include Norton Healthcare Ltd, Orvet UK, and Teva NI Limited.

The business operates through multiple revenue streams: high-volume generic pharmaceutical sales via the TevaOne scheme for independent pharmacists and dispensing doctors, branded/specialty medicines across CNS disorders, respiratory diseases, pain, and oncology sold through NHS procurement frameworks and pharmaceutical wholesalers, and consumer healthcare OTC products. The company is one of the largest suppliers to the NHS and contributes to industry-wide generic savings exceeding £13 billion annually. Distribution is restricted to UK registered pharmaceutical wholesalers plus the direct TevaOne pharmacy channel; international export is conducted from Runcorn for global markets.

Teva UK combines traditional pharmaceutical manufacturing scale with selective digital health innovation, notably the GoResp Digihaler launched in July 2023 — a sensor-enabled smart inhaler for asthma and COPD management. The company voluntarily complies with the ABPI Code of Practice, holds OHSAS 18001 certification at its Castleford distribution centre, complies with UK GDPR and Modern Slavery Act requirements, and operates a five-star rated British Safety Council audited workplace. Go-to-market is primarily sales-led via medical representatives targeting NHS organizations, pharmacies, and healthcare professionals, supplemented by the TevaOne channel partner scheme and patient/caregiver engagement through the Life Effects program.

Short descriptiontext

Teva UK Limited, a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd, develops, manufactures, and supplies generic, innovative, biosimilar, and OTC medicines across four UK sites, serving the NHS, independent pharmacists, and consumer healthcare markets with 650+ product lines.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersEastbourne, United Kingdom
HQ citystring
Eastbourne
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceuticals, prescription medicines, biosimilar medicines, consumer healthcare, respiratory devices
Industry3 codes
PRIMARYCRADAMAK
Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYTLAIACAD
Pharmaceutical & Life Sciences Warehousing (GDP-Compliant)
Transportation & Logistics/Third-Party & Fourth-Party Logistics (3PL/4PL) / Contract Logistics/Warehousing Operations & Contract Storage (Dedicated/Shared)
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Surgical & Medical Instruments & Apparatus3841
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Generic Pharmaceuticals
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Generic Pharmaceuticals
TypeOne Time License
Description

The backbone of Teva UK's business is generic pharmaceuticals. The company manufactures and distributes high-quality generic medicines containing the same active ingredients as branded equivalents. These are sold to pharmacies and dispensing doctors through the TevaOne scheme, generating revenue through volume-based sales of 650+ product lines.

tevauk.com
2Branded/Specialty Medicines
TypeOne Time License
Description

Range of branded products used in primary and secondary care across CNS disorders, respiratory, pain, oncology, and other specialty therapy areas. Sold through standard pharmaceutical distribution channels.

tevauk.com
3Consumer Healthcare Products
TypeOne Time License
Description

Over-the-counter products available without prescription including well-known brands such as Sudocrem and Infacol in baby care sector, and Motusol.

tevauk.com
4Digital Therapeutics/Devices
TypeHardware Sales
Description

Smart inhaler products and digital health solutions like the GoResp Digihaler combining drug delivery with connected technology for respiratory disease management.

tevauk.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Sudocrem
Description

Over-the-counter baby care product available without prescription

tevauk.com:443
+5 more records
Core offering1 text field

Teva UK Limited develops, manufactures and supplies innovative, generic, biosimilar and over-the-counter medicines across multiple therapy areas including central nervous system disorders, respiratory diseases, pain management and oncology. The company operates manufacturing facilities in Runcorn (sterile liquid products, respiratory and neurological treatments) and Larne (hormonal rings, intrauterine devices), with a logistics centre and head office in Castleford and a regulatory affairs centre in Harlow. Its portfolio spans 650+ generic product lines, branded innovative medicines, consumer healthcare brands (Sudocrem, Infacol, Motusol) and connected respiratory devices such as the GoResp Digihaler.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • NHS savings of over £13 billion per annum through generic medicines
+2 more records
Product overview1 text field

Teva UK Limited is one of the largest pharmaceutical companies in the UK, operating across the full spectrum of innovation from generic medicines to innovative branded products and biosimilars. The company offers a diverse portfolio spanning prescription medicines used in primary and secondary care, covering therapeutic areas including central nervous system disorders, migraine, respiratory diseases, pain management, and oncology. Teva UK's product offerings include over 650 generic pharmaceutical product lines distributed through the TevaONE pharmacy support program, branded innovative medicines, consumer healthcare products (Sudocrem, Infacol, Motusol), and advanced respiratory devices including the GoResp Digihaler with smart inhaler technology. The company operates manufacturing facilities in Runcorn and Larne, with distribution operations centered in Castleford, serving millions of patients throughout the UK NHS.

Product and service7 records
1GoResp Digihaler
Categoryrespiratory medical device
Description

Smart inhaler equipped with sensor technology that tracks inhaler usage, generates usage data, and connects to digital health platforms for improved respiratory disease management in asthma and COPD patients. Breath-activated with E-connectivity for healthcare professional insight into patient adherence and condition control.

2Generic Medicines Portfolio
Categorygeneric pharmaceuticals
Description

Wide range of generic pharmaceutical products containing the same active ingredients as original brand-name medicines, available in various forms including tablets, capsules, oral solutions and suspensions, comprising 650+ product lines distributed through UK wholesalers and the TevaOne scheme.

3Branded and Innovative Medicines
Categoryprescription pharmaceuticals
Description

Prescription medicines developed through research and development, including treatments for central nervous system disorders, migraine, respiratory diseases, pain and cancer, supplied through NHS and pharmaceutical wholesale channels for primary and secondary care use.

4Sudocrem
Categoryconsumer healthcare
Description

Over-the-counter baby care product available without prescription for diaper rash and skin care, supplied through pharmacy and retail channels to UK consumers.

5Infacol
Categoryconsumer healthcare
Description

Over-the-counter product for infant colic relief, available without prescription through pharmacy retail in the UK.

6Motusol
Categoryconsumer healthcare
Description

Over-the-counter topical diclofenac product for pain relief, recently introduced to the consumer healthcare range and available without prescription in the UK.

7TevaOne Pharmacy Scheme
Categorypharmacy support service
Description

Pharmacy support scheme for independent pharmacists and dispensing doctors' surgeries offering direct access to 650+ generic product lines, lower retail prices, more discountable lines, monthly rebates on spend from £750, and dedicated business manager support.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1NHS
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Teva UK is a key partner for the NHS, being one of the largest suppliers of medicines to the NHS. The company works with NHS organisations at national, regional and local level, focusing on improving patient outcomes by implementing developments in healthcare delivery. This includes collaborating on clinical trials, providing medical information, and supporting healthcare professionals.

tevauk.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers9 records
1Sandoz
TypeDirect peer
Description

Sandoz is the global generic pharmaceuticals division of Novartis, directly competing with Teva UK in generic medicines supply to the NHS, hospital injectables, and biosimilars. As the world's largest dedicated generics business, Sandoz is Teva UK's closest direct competitor in the UK market.

TypeBroad incumbent
Description

AstraZeneca is a UK-headquartered global pharmaceutical leader with major respiratory franchise (Symbicort, Fasenra, Trixeo). As a broader incumbent, it competes with Teva UK in respiratory and oncology while operating in biologics and rare disease beyond generics.

TypeDirect peer
Description

Dr. Reddy's is a leading Indian-headquartered global generic pharmaceutical company with UK operations supplying the NHS. It directly competes with Teva UK in generic pharmaceuticals, biosimilars, and OTC consumer healthcare.

TypeDirect peer
Description

Viatris (formed from Mylan and Upjohn) is a major global generic and biosimilar manufacturer with a significant UK presence. It directly competes with Teva UK across generic pharmaceuticals, OTC brands, and active pharmaceutical ingredient supply.

TypeDirect peer
Description

Aurobindo Pharma is a major Indian-headquartered global generic manufacturer with UK operations and significant NHS supply. It directly competes with Teva UK across oral solid generics, injectables, and active pharmaceutical ingredients.

TypeBroad incumbent
Description

GSK is a UK-headquartered global pharmaceutical giant with a leading respiratory franchise (Trelegy, Relvar Ellipta). As a broader incumbent, GSK competes with Teva UK in respiratory medicines and consumer healthcare while operating across vaccines and specialty medicines beyond Teva's generics focus.

TypeDirect peer
Description

Hikma Pharmaceuticals is a UK-listed (FTSE 100) generic and specialty pharmaceutical manufacturer headquartered in London. It directly competes with Teva UK in generic injectables, oral generics, and respiratory medicines supplied to the NHS.

TypeDirect peer
Description

Zentiva is a European-focused generic pharmaceutical manufacturer headquartered in Prague with significant UK market presence. It directly competes with Teva UK in generic pharmaceuticals, particularly cardiovascular and CNS categories distributed through UK wholesalers.

TypeDirect peer
Description

Accord Healthcare, the UK subsidiary of India's Intas Pharmaceuticals, is one of the fastest-growing generic pharmaceutical companies supplying the NHS. It directly competes with Teva UK on generic medicines, oncology injectables, and biosimilars.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Teva Uk Limited

Generic Pharmaceuticalstevauk.com

Teva UK Limited, a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd, develops, manufactures, and supplies generic, innovative, biosimilar, and OTC medicines across four UK sites, serving the NHS, independent pharmacists, and consumer healthcare markets with 650+ product lines.

What Teva Uk Limited does

Teva UK Limited is a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and one of the largest pharmaceutical companies operating in the United Kingdom. The company develops, manufactures, and supplies a portfolio spanning generic medicines, innovative branded products, biosimilars, and over-the-counter consumer healthcare brands (Sudocrem, Infacol, Motusol), with 650+ generic product lines distributed to millions of UK patients daily. UK operations are anchored by four sites: Castleford (headquarters and high-tech logistics centre), Runcorn (sterile liquid manufacturing for respiratory and neurological treatments, serving global markets), Harlow (Centre of Excellence for Regulatory Affairs covering European and global licensing), and Larne (hormonal ring manufacturing and intrauterine device R&D). Wholly-owned subsidiaries include Norton Healthcare Ltd, Orvet UK, and Teva NI Limited.

The business operates through multiple revenue streams: high-volume generic pharmaceutical sales via the TevaOne scheme for independent pharmacists and dispensing doctors, branded/specialty medicines across CNS disorders, respiratory diseases, pain, and oncology sold through NHS procurement frameworks and pharmaceutical wholesalers, and consumer healthcare OTC products. The company is one of the largest suppliers to the NHS and contributes to industry-wide generic savings exceeding £13 billion annually. Distribution is restricted to UK registered pharmaceutical wholesalers plus the direct TevaOne pharmacy channel; international export is conducted from Runcorn for global markets.

Teva UK combines traditional pharmaceutical manufacturing scale with selective digital health innovation, notably the GoResp Digihaler launched in July 2023 — a sensor-enabled smart inhaler for asthma and COPD management. The company voluntarily complies with the ABPI Code of Practice, holds OHSAS 18001 certification at its Castleford distribution centre, complies with UK GDPR and Modern Slavery Act requirements, and operates a five-star rated British Safety Council audited workplace. Go-to-market is primarily sales-led via medical representatives targeting NHS organizations, pharmacies, and healthcare professionals, supplemented by the TevaOne channel partner scheme and patient/caregiver engagement through the Life Effects program.

Teva Uk Limited firmographics

Firmographics
Name
Teva Uk Limited
Legal name
Teva UK Limited
Website
https://tevauk.com
Company type
Private
Operating status
Operating
Headcount range
51–100 employees
Short description
Teva UK Limited, a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd, develops, manufactures, and supplies generic, innovative, biosimilar, and OTC medicines across four UK sites, serving the NHS, independent pharmacists, and consumer healthcare markets with 650+ product lines.
Ownership category
akta.pro rank

Teva Uk Limited industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRADAMAK
Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYTLAIACAD
Pharmaceutical & Life Sciences Warehousing (GDP-Compliant)
Transportation & Logistics/Third-Party & Fourth-Party Logistics (3PL/4PL) / Contract Logistics/Warehousing Operations & Contract Storage (Dedicated/Shared)

Keywords

  • Generic pharmaceuticals
  • Prescription medicines
  • Biosimilar medicines
  • Consumer healthcare
  • Respiratory devices

Where Teva Uk Limited is headquartered

Location

Headquarters

HQ city
Eastbourne
HQ country
United Kingdom
HQ region
Europe

Offices4 records

Markets served

Teva Uk Limited business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Generic Pharmaceuticals: The backbone of Teva UK's business is generic pharmaceuticals. The company manufactures and distributes high-quality generic medicines containing the same active ingredients as branded equivalents. These are sold to pharmacies and dispensing doctors through the TevaOne scheme, generating revenue through volume-based sales of 650+ product lines.
  2. Branded/Specialty Medicines: Range of branded products used in primary and secondary care across CNS disorders, respiratory, pain, oncology, and other specialty therapy areas. Sold through standard pharmaceutical distribution channels.
  3. Consumer Healthcare Products: Over-the-counter products available without prescription including well-known brands such as Sudocrem and Infacol in baby care sector, and Motusol.
  4. Digital Therapeutics/Devices: Smart inhaler products and digital health solutions like the GoResp Digihaler combining drug delivery with connected technology for respiratory disease management.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Teva Uk Limited product offering

Product offering

Core offering

Teva UK Limited develops, manufactures and supplies innovative, generic, biosimilar and over-the-counter medicines across multiple therapy areas including central nervous system disorders, respiratory diseases, pain management and oncology. The company operates manufacturing facilities in Runcorn (sterile liquid products, respiratory and neurological treatments) and Larne (hormonal rings, intrauterine devices), with a logistics centre and head office in Castleford and a regulatory affairs centre in Harlow. Its portfolio spans 650+ generic product lines, branded innovative medicines, consumer healthcare brands (Sudocrem, Infacol, Motusol) and connected respiratory devices such as the GoResp Digihaler.

Product overview

Teva UK Limited is one of the largest pharmaceutical companies in the UK, operating across the full spectrum of innovation from generic medicines to innovative branded products and biosimilars. The company offers a diverse portfolio spanning prescription medicines used in primary and secondary care, covering therapeutic areas including central nervous system disorders, migraine, respiratory diseases, pain management, and oncology. Teva UK's product offerings include over 650 generic pharmaceutical product lines distributed through the TevaONE pharmacy support program, branded innovative medicines, consumer healthcare products (Sudocrem, Infacol, Motusol), and advanced respiratory devices including the GoResp Digihaler with smart inhaler technology. The company operates manufacturing facilities in Runcorn and Larne, with distribution operations centered in Castleford, serving millions of patients throughout the UK NHS.

Differentiator

Problem solved

Functional benefit

Brands

  • Sudocrem: Over-the-counter baby care product available without prescription
  • Infacol
  • Motusol
  • TevaOne
  • GoResp Digihaler
  • TevaONE LifeEffects

Products and services

  • GoResp Digihaler Smart inhaler equipped with sensor technology that tracks inhaler usage, generates usage data, and connects to digital health platforms for improved respiratory disease management in asthma and COPD patients. Breath-activated with E-connectivity for healthcare professional insight into patient adherence and condition control.
  • Generic Medicines Portfolio Wide range of generic pharmaceutical products containing the same active ingredients as original brand-name medicines, available in various forms including tablets, capsules, oral solutions and suspensions, comprising 650+ product lines distributed through UK wholesalers and the TevaOne scheme.
  • Branded and Innovative Medicines Prescription medicines developed through research and development, including treatments for central nervous system disorders, migraine, respiratory diseases, pain and cancer, supplied through NHS and pharmaceutical wholesale channels for primary and secondary care use.
  • Sudocrem Over-the-counter baby care product available without prescription for diaper rash and skin care, supplied through pharmacy and retail channels to UK consumers.
  • Infacol Over-the-counter product for infant colic relief, available without prescription through pharmacy retail in the UK.
  • Motusol Over-the-counter topical diclofenac product for pain relief, recently introduced to the consumer healthcare range and available without prescription in the UK.
  • TevaOne Pharmacy Scheme Pharmacy support scheme for independent pharmacists and dispensing doctors' surgeries offering direct access to 650+ generic product lines, lower retail prices, more discountable lines, monthly rebates on spend from £750, and dedicated business manager support.

Quantifiable outcome

  • NHS savings of over £13 billion per annum through generic medicines
  • +2 more outcomes

Companies that use Teva Uk Limited

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Teva Uk Limited technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature2 records

Teva Uk Limited partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • NHScoreStrategic or Co-development PartnerTeva UK is a key partner for the NHS, being one of the largest suppliers of medicines to the NHS. The company works with NHS organisations at national, regional and local level, focusing on improving patient outcomes by implementing developments in healthcare delivery. This includes collaborating on clinical trials, providing medical information, and supporting healthcare professionals.

Scale indicators6 records

Recent moves5 records

Expansion highlights6 records

Teva Uk Limited competitors and assessment

Company assessment

Direct peers

  • Sandoz: Sandoz is the global generic pharmaceuticals division of Novartis, directly competing with Teva UK in generic medicines supply to the NHS, hospital injectables, and biosimilars. As the world's largest dedicated generics business, Sandoz is Teva UK's closest direct competitor in the UK market.
  • Dr. Reddy's Laboratories: Dr. Reddy's is a leading Indian-headquartered global generic pharmaceutical company with UK operations supplying the NHS. It directly competes with Teva UK in generic pharmaceuticals, biosimilars, and OTC consumer healthcare.
  • Viatris: Viatris (formed from Mylan and Upjohn) is a major global generic and biosimilar manufacturer with a significant UK presence. It directly competes with Teva UK across generic pharmaceuticals, OTC brands, and active pharmaceutical ingredient supply.
  • Aurobindo Pharma: Aurobindo Pharma is a major Indian-headquartered global generic manufacturer with UK operations and significant NHS supply. It directly competes with Teva UK across oral solid generics, injectables, and active pharmaceutical ingredients.
  • Hikma Pharmaceuticals: Hikma Pharmaceuticals is a UK-listed (FTSE 100) generic and specialty pharmaceutical manufacturer headquartered in London. It directly competes with Teva UK in generic injectables, oral generics, and respiratory medicines supplied to the NHS.
  • Zentiva: Zentiva is a European-focused generic pharmaceutical manufacturer headquartered in Prague with significant UK market presence. It directly competes with Teva UK in generic pharmaceuticals, particularly cardiovascular and CNS categories distributed through UK wholesalers.
  • Accord Healthcare: Accord Healthcare, the UK subsidiary of India's Intas Pharmaceuticals, is one of the fastest-growing generic pharmaceutical companies supplying the NHS. It directly competes with Teva UK on generic medicines, oncology injectables, and biosimilars.

Broad incumbents

  • AstraZeneca: AstraZeneca is a UK-headquartered global pharmaceutical leader with major respiratory franchise (Symbicort, Fasenra, Trixeo). As a broader incumbent, it competes with Teva UK in respiratory and oncology while operating in biologics and rare disease beyond generics.
  • GSK: GSK is a UK-headquartered global pharmaceutical giant with a leading respiratory franchise (Trelegy, Relvar Ellipta). As a broader incumbent, GSK competes with Teva UK in respiratory medicines and consumer healthcare while operating across vaccines and specialty medicines beyond Teva's generics focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Teva Uk Limited social profiles

Digital presence

Teva Uk Limited compliance and trust

Trust signal

Compliance4 records

Teva Uk Limited financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Teva Uk Limited leadership team

Management profile

Number of profiles

Teva Uk Limited subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Teva Uk Limited funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Teva Uk Limited M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Teva Uk Limited

What does Teva Uk Limited do?

Teva UK Limited develops, manufactures and supplies innovative, generic, biosimilar and over-the-counter medicines across multiple therapy areas including central nervous system disorders, respiratory diseases, pain management and oncology. The company operates manufacturing facilities in Runcorn (sterile liquid products, respiratory and neurological treatments) and Larne (hormonal rings, intrauterine devices), with a logistics centre and head office in Castleford and a regulatory affairs centre in Harlow. Its portfolio spans 650+ generic product lines, branded innovative medicines, consumer healthcare brands (Sudocrem, Infacol, Motusol) and connected respiratory devices such as the GoResp Digihaler.

Is Teva Uk Limited a public or private company?

Teva Uk Limited is a private company. It is classified as corporate owned and is currently operating.

When was Teva Uk Limited founded?

Teva Uk Limited was founded in -1. It employs 51 to 100 people.

Where is Teva Uk Limited based?

Teva Uk Limited is headquartered in Eastbourne, United Kingdom, in the Europe region.

How does Teva Uk Limited make money?

Four revenue lines are on record. Generic Pharmaceuticals are the primary driver. The others are branded/Specialty Medicines, consumer Healthcare Products and digital Therapeutics/Devices.

Who are Teva Uk Limited's main competitors?

Direct peers on record are Sandoz, Dr. Reddy's Laboratories, Viatris, Aurobindo Pharma, Hikma Pharmaceuticals, Zentiva and Accord Healthcare. Broad incumbents are AstraZeneca and GSK.

Does Teva Uk Limited have an API?

No public API is recorded for Teva Uk Limited.

What industry is Teva Uk Limited in?

Teva Uk Limited's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is CRADAMAK, Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests), with a secondary code of HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The GuardianSecond UK health body drops Israeli drug firm after activist pressureThe Royal College of Pharmacy cut ties with Teva UK, ending its sponsorship and exhibition presence at its annual conference. The decision followed a due diligence review citing Teva's activities not aligning with the college's values, after the RCN had already dropped Teva. UKHPRC urged other royal colleges to follow suit.ArabnewsUK nursing union cuts ties with Israeli drugs firmThe Royal College of Nursing cut its commercial partnership with Teva UK, an Israeli pharmaceutical firm, after pressure from Palestinian rights groups. Teva has paid about $1.3 billion in fines for bribery, price-fixing, and market abuse. The union will no longer sponsor its upcoming migraine and headache event.News-MedicalTeva UK and Closed Loop Medicine announce strategic partnership to advance development of personalised medicinesTeva UK and Closed Loop Medicine announced a strategic partnership to develop personalized medicines using Closed Loop Medicine's software as a medical device (SaMD) platform. The partnership aims to combine dose-optimized drug therapy with digital care, with recent trial results for CLM-HT01 showing improved blood pressure control and adherence. The collaboration seeks to integrate real-world data to personalize dosing.Roots AnalysisPrecision Medicine Software Market, Size, Share and TrendsThe global precision medicine software market is projected to grow from USD 43 million in 2025 to USD 324 million by 2032, driven by increasing demand for personalized treatments and advancements in AI and genomic data analysis. Key industry developments include SimBioSys receiving FDA clearance for its TumorSight™ application and Teva UK collaborating with Closed Loop Medicine to enhance personalized drug therapies.PharmaTimesUK launch for Ajovy injector penTeva UK launched a pre-filled pen for Ajovy (fremanezumab) injection, offering a convenient self-administration option for migraine prevention. The device, developed in the UK, includes a button-free push-down mechanism and audible cues, and is the first anti-CGRP drug recommended by NICE for chronic migraine in England and Wales.